SCHEMBL22818065

SCHEMBL22818065

c1ccc(-c2ccccc2N(c2cc3c(oc4cccc(-c5ccccc5)c43)c3ccccc23)c2cccc3c2oc2ccccc23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 3/20 0.40
▸ GGPS1 O95749 1/20 0.35
▸ CDC14B O60729 1/20 0.34
▸ CDC14A Q9UNH5 1/20 0.34
▸ PTGES2 Q9H7Z7 1/20 0.33
▸ PRKDC P78527 5/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ PDGFRB P09619 1/20 0.32
▸ KIT P10721 1/20 0.32
▸ FLT3 P36888 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ CYP1B1 Q16678 2/20 0.31
▸ CYP3A4 P08684 2/20 0.31
▸ HPGD P15428 2/20 0.31
▸ AHR P35869 1/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22818278 0.98 ALOX5 (0.41) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL22818084 0.95 ALOX5 (0.40) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL22818149 0.95 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL15851667 0.94 ALOX5 (0.43) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL22818390 0.93 ALOX5 (0.38) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL15852068 0.93 ALOX5 (0.39) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL15852179 0.93 ALOX5 (0.42) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL16185363 0.92 ALOX5 (0.44) ALOX5GGPS1CDC14BCDC14APTGES2
SCHEMBL22818436 0.92 ALOX5 (0.40) ALOX5GGPS1PTGES2PRKDCMEN1
SCHEMBL15851634 0.90 ALOX5 (0.46) ALOX5GGPS1CDC14BCDC14APTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885CDC14B 589/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885CDC14B 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback